Rare Diseases in South Africa: Bridging the Gap for Inclusive Healthcare
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Address: 72 Steel Road Spartan , Kempton Park ,South Africa
Tel: +27 11975 0654
Sandoz, the generic pharmaceuticals division of the Novartis Group, is a global leader in the rapidly growing generics industry. With quality going back to its roots in the 19th century, Sandoz has a strong global presence covering 90% of the world’s population. We are committed to providing healthcare products and services of a consistently high standard, worldwide. We believe that consistent and reliable quality is what sets us apart from our competition, by offering customers the safety and efficacy associated with reference medicines, at lower cost.
At Sandoz we make far more than just traditional off-patent medicines. We develop and manufacture a wide range of difficult-to-make medicines, ranging from complex delivery systems for standard generics through to modern biopharmaceutical medicines (biosimilars).
Adhering to one, uniform standard, Sandoz South Africa supplies a comprehensive range of medicines for just about every therapeutic area, from Cardiovascular, Anti-Infectives, CNS, Analgesics, and the challenging field of TB.
Our core business lies in the development, production and distribution of high-quality, affordable generic medicines. We offer approximately 1 000 generic compounds worldwide and are a leading provider of differentiated, value-added products, including state-of-the-art biosimilars, injectables, inhalers and transdermal patches.
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a registered NPO born out of necessity when her oldest child was diagnosed with Pompe disease at 11…
Trailing behind South Africa’s pharmaceutical market in both value and growth, the nation’s medical device industry has long enjoyed minimal barriers to entry and easy market access. But, with imminent…
The traditional model of healthcare has generally been limited to treatment in health facilities. But, when it comes to effectively treating more private and deeply personal health conditions, especially in…
Eclectic demographics, rapid patient recruitment, and a burgeoning population with a gradient of disease profiles—these seem to be the fundamentals truly driving growth in South Africa’s clinical trial industry. However,…
While South Africa faces a distinct set of challenges in effectively managing its healthcare sector, the ecosystem for innovation, particularly in the world of biotechnology remains fruitful. Bioentrepreneur Nick Duneas…
Hersol prides itself on producing high-quality products and is today one of the leading Pharmaceutical Contract Manufacturing Companies (CMOs) within the South African Market. The managing director discusses the development…
Albert Denoon (AB) and Jeff Hampton (JH) illustrate how the Crossroads and Campbell Institutes, two non-profit organizations funded by Baroque Medical, are well positioned to address South Africa’s current gaps…
The general manager of Bard SA, Charl De Klerk, illustrates the company’s growth ambitions within South Africa and Sub-Saharan Africa, while also depicting how Bard has adapted its therapeutic portfolio…
The head of KPMG’s life science division in Africa, Joubert Krugel, discusses the current state of South Africa’s healthcare system, the imminent trends taking place, and how the business community…
Marius Fourie highlights implications of the recent merger between the company’s two subsidiaries and the unparalleled levels of value and service the consolidated organization will offer. He also illustrates the affiliate’s strategies…
Tania Zulu Holt, Associate Principal at McKinsey & Company elaborates on the current pressures on the South African healthcare system, discusses the importance of innovation and emphasizes the need for…
Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare…
See our Cookie Privacy Policy Here
